...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

** BETonMACE Phase 3 Cardio Outcomes Trial for Apabetalone Has Reached its Targeted 250 MACE Events ** Top-Line Data Expected Mid-Year 2019 https://clinicaltrials.gov/ct2/show/NCT02586155

Message: Nice volatility

Yo yo shaking up and down but we see  to have broken free of the $3 support level.....need another week of trading þo see where things settle

New Message
Please login to post a reply